Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-015611
Filing Date
2020-08-14
Accepted
2020-08-13 20:51:10
Documents
62
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 404768
2 ex31-1.htm EX-31.1 17288
3 ex31-2.htm EX-31.2 17701
4 ex-32.htm EX-32 10019
  Complete submission text file 0001493152-20-015611.txt   2752201

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE hjli-20200630.xml EX-101.INS 359285
6 XBRL SCHEMA FILE hjli-20200630.xsd EX-101.SCH 54584
7 XBRL CALCULATION FILE hjli-20200630_cal.xml EX-101.CAL 51086
8 XBRL DEFINITION FILE hjli-20200630_def.xml EX-101.DEF 145703
9 XBRL LABEL FILE hjli-20200630_lab.xml EX-101.LAB 294767
10 XBRL PRESENTATION FILE hjli-20200630_pre.xml EX-101.PRE 209092
Mailing Address 70 DOPPLER IRVINE CA 92618
Business Address 70 DOPPLER IRVINE CA 92618 949-261-2900
Hancock Jaffe Laboratories, Inc. (Filer) CIK: 0001661053 (see all company filings)

EIN.: 330936180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38325 | Film No.: 201100998
SIC: 3841 Surgical & Medical Instruments & Apparatus